FDA Biologics (BLA & Biosimilars)Original article
Expedited IND Pilot Program Educational Webinar for Stakeholders - 08/06/2026
Neutral
AI Analysis
Summary
The FDA is hosting an educational webinar on August 6, 2026, to discuss a proposed Expedited IND pilot program designed to accelerate the timeline from drug identification to first-in-human clinical trials.
Importance:2/10
Sentiment:
0.00
FDAINDExpedited ProgramEducational WebinarClinical Development
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on July 27, 2026 3:52 PM